Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Scherer granted U.S. patent for ascorbic acid in softgel delivery system

April 14, 1997

Connetics commences phase III trial for betamethasone mousse

April 8, 1997

Human skin equivalent approved in Canada

April 8, 1997

Clinical efficacy and safety of Aphthasol reviewed

April 7, 1997

ProCyte reports results from hair growth trial

April 7, 1997

Pharmadigm's PB-OO5 enters phase II as burn treatment

April 2, 1997

ICOS initiates phase I with monoclonal antibody

April 1, 1997

Antiinflammatory compounds disclosed by Tsumura

April 1, 1997

Name change for Connective Therapeutics; patient enrollment completed in pivotal interferon trial

March 25, 1997

Additional U.S. patent issued for Cariel

March 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.